Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome. [PDF]
Weisinger J+17 more
europepmc +1 more source
Complement activation in thrombotic thrombocytopenic purpura [PDF]
Alvarez-Larran+28 more
core +1 more source
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study. [PDF]
Mavrikou I+16 more
europepmc +1 more source
Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy. [PDF]
Seby R+8 more
europepmc +1 more source
ADAMTS13 deficiency with elevated levels of ultra-large and active von Willebrand factor in P. falciparum and P. vivax malaria. [PDF]
A deficiency in ADAMTS13 (a von Willebrand factor [VWF] cleaving protease) is associated with accumulation of prothrombogenic unusually large VWF multimers (UL-VWF) in plasma. We studied VWF release and proteolysis in patients with symptomatic Plasmodium
Syafruddin D
core
The Hideous Side of Acute Pancreatitis: A Case of Pancreatitis-Induced Atypical Hemolytic Uremic Syndrome. [PDF]
Al-Ali H, Elmogy A, Arsh H, Rhee H.
europepmc +1 more source
Systemic Lupus Erythematosus-Associated Thrombotic Thrombocytopenic Purpura: A Case Report. [PDF]
Es-Saad O+4 more
europepmc +1 more source
Is COVID-19 Coagulopathy a Thrombotic Microangiopathy? A Prospective, Observational Study. [PDF]
Silingardi M+14 more
europepmc +1 more source
Estimating rare genetic disease prevalence: a challenging task. [PDF]
Kokame K.
europepmc +1 more source
Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis. [PDF]
Liu Y+9 more
europepmc +1 more source